Table 3.
Variable
|
High expression (n = 44)
|
Low expression (n = 67)
|
P value
|
Gender (M/F) | 37/7 | 56/11 | 0.944 |
Age (year) | 54.73 ± 8.56 | 54.63 ± 9.67 | 0.814 |
Hepatitis (HBV/HCV/none) | 36/4/4 | 52/9/5 | 0.487 |
Cirrhosis (Y/N) | 32/12 | 64/2 | 0.25 |
MELD score | 7.67 (5.57-9.65) | 6.62 (5.43-8.09) | 0.071 |
Number of tumors (multiple/single) | 30/14 | 33/34 | 0.05 |
Maximum diameter of tumor (cm) | 3.50 (2.00-6.00) | 3.00 (2.00-6.00) | 0.954 |
Satellite cooker (Y/N) | 12/32 | 11/56 | 0.169 |
MVI (Y/N) | 16/28 | 12/55 | 0.029 |
Tumor differentiation (well/moderate/poor/undifferentiation) | 0/28/15/1 | 1/40/19/7 | 0.649 |
Clinicopathological stage (I/II/III/IV) | 7/12/25/0 | 20/22/25/0 | 0.032 |
Relapse states (N/Y) | 22/22 | 47/22 | 0.002 |
Vital states (alive/dead) | 25/19 | 56/11 | 0.033 |
Y: Yes; N: No; M: Male; F: Female; MELD: Model for end-stage liver disease; HBV: Hepatitis B virus; HCV: Hepatitis C virus.